Company Profile
BriaCell Stock Price, News & Analysis
- Ticker:
- BCTX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Canada
Stock performance
3.45 USD (-1.43%)
Close
Last updated: August 6, 2026
23.7M USD
Market cap
Why the stock is moving
Following the latest company update, “BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer”, BCTX closed up 3.86% at $3.50 on Aug 5, 2026. The move occurred in the trading session associated with this fda / regulatory update.
Company overview
Business overview
BriaCell is an immuno-oncology company focused on cancer vaccines and cellular immunotherapy. Its platform aims to create targeted immune responses against tumors.
Geographic Base and Sector Classification
Headquartered in Canada and listed on NASDAQ, BriaCell has a cross-border cancer-biotech profile.
Business Model Characteristics
The company depends on clinical data, immunotherapy differentiation, and the ability to create a niche oncology franchise.
Position Within the Biotechnology Landscape
BriaCell is a high-beta immunotherapy name whose valuation is highly sensitive to early clinical updates.
Future catalysts
BriaCell’s catalysts are Bria-IMT and its oncology immunotherapy platform, especially any readout that shows the company can keep advancing toward a viable clinical profile. The stock is driven by binary data.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of BriaCell (BCTX)?
BriaCell (BCTX) most recently closed at 3.45 USD, a -1.43% move versus the previous session.
What is the market cap of BriaCell (BCTX)?
BriaCell currently has a market capitalization of 23.7M USD on BioPharmSignal.
What does BriaCell do?
BriaCell is an immuno-oncology company focused on cancer vaccines and cellular immunotherapy. Its platform aims to create targeted immune responses against tumors.
On which exchange is BCTX stock listed?
BriaCell (BCTX) is associated with NASDAQ, Canada, Biopharma.
What is BriaCell?
BriaCell’s catalysts are Bria-IMT and its oncology immunotherapy platform, especially any readout that shows the company can keep advancing toward a viable clinical profile.
Which conditions is BriaCell targeting with BriaCell?
BriaCell is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does BriaCell describe recent progress with BriaCell?
BriaCell’s catalysts are Bria-IMT and its oncology immunotherapy platform, especially any readout that shows the company can keep advancing toward a viable clinical profile.
What is Bria-IMT?
BriaCell’s catalysts are Bria-IMT and its oncology immunotherapy platform, especially any readout that shows the company can keep advancing toward a viable clinical profile.